Differences in nutritional status between very mild Alzheimer's disease patients and healthy controls

Journal of Alzheimer's Disease

Volumn 41, Issue 1, 2014, Pages 261-271

  Olde Rikkert, Marcel G M ^a,j   Verhey, Frans R ^b   Sijben, John W C ^c   Bouwman, Femke H ^d,j   Dautzenberg, Paul L J ^e   Lansink, Mirian ^c   Sipers, Walther M W ^f   Van Asselt, Dieneke Z B ^g   Van Hees, Anneke M J ^c   Stevens, Martijn ^h   Vellas, Bruno ⁱ   Scheltens, Philip ^j  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^c Nutricia Nederland   (Netherlands)

^d CATHARINA HOSPITAL   (Netherlands)

^e JEROEN BOSCH HOSPITAL   (Netherlands)

^f Zuyderland Medical Centre   (Netherlands)

^g MEDICAL CENTER LEEUWARDEN   (Netherlands)

^h TERGOOI HOSPITAL   (Netherlands)

ⁱ UMR INSERM 1027   (France)

^j VU UNIVERSITY MEDICAL CENTER   (Netherlands)

more..

Author keywords

Alzheimer's disease; fatty acids; healthy volunteers; micronutrients; nutritional status; protein energy malnutrition

Indexed keywords

ALPHA TOCOPHEROL; ARACHIDONIC ACID; CALCIUM; CHOLINE; CYANOCOBALAMIN; DIHOMO GAMMA LINOLENIC ACID; DOCOSAPENTAENOIC ACID; ELAIDIC ACID; FATTY ACID; FOLIC ACID; GAMMA LINOLENIC ACID; HOMOCYSTEINE; HYDROXOCOBALAMIN; LINOLEIC ACID; LINOLENIC ACID; MEMBRANE LIPID; MULTIVITAMIN; OLEIC ACID; PALMITIC ACID; PHOSPHOLIPID; PYRIDOXINE; RETINOL; SELENIUM; STEARIC ACID; STEARIDONIC ACID; TRACE ELEMENT; URIDINE; VACCENIC ACID; VITAMIN B COMPLEX; VITAMIN D;

ADULT; AGED; ALZHEIMER DISEASE; ANTHROPOMETRIC PARAMETERS; ARTICLE; CONTROLLED STUDY; DIET SUPPLEMENTATION; DISEASE SEVERITY; ERYTHROCYTE MEMBRANE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MALNUTRITION; MINI MENTAL STATE EXAMINATION; NUTRITIONAL ASSESSMENT; NUTRITIONAL STATUS; PHOSPHOLIPID BLOOD LEVEL; PRIORITY JOURNAL; PROTEIN CALORIE MALNUTRITION; QUESTIONNAIRE; RISK FACTOR; SCREENING; SELENIUM BLOOD LEVEL; VERY ELDERLY; VITAMIN BLOOD LEVEL; ANTHROPOMETRY; BLOOD; BLOOD ANALYSIS; CELL MEMBRANE; CLINICAL TRIAL; ERYTHROCYTE; METABOLISM; MIDDLE AGED; MULTICENTER STUDY; NETHERLANDS; NEUROPSYCHOLOGICAL TEST; PHYSIOLOGY; PROTEIN-ENERGY MALNUTRITION;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; ANTHROPOMETRY; BLOOD CHEMICAL ANALYSIS; CELL MEMBRANE; ERYTHROCYTES; FATTY ACIDS; FEMALE; HUMANS; MALE; MICRONUTRIENTS; MIDDLE AGED; NETHERLANDS; NEUROPSYCHOLOGICAL TESTS; NUTRITIONAL STATUS; PROTEIN-ENERGY MALNUTRITION; QUESTIONNAIRES; SELENIUM; URIDINE; VITAMIN D;

EID: 84899633911     PISSN: 13872877     EISSN: 18758908     Source Type: Journal    
DOI: 10.3233/JAD-131892     Document Type: Article

References (68)

1. Citron M (2002) Alzheimer's disease: Treatments in discovery and development. Nat Neurosci 5 Suppl, 1055-1057.
2. Gillette Guyonnet S, Abellan Van Kan G, Andrieu S, Bar-berger Gateau P, Berr C, Bonnefoy M, Dartigues JF, de Groot L, Ferry M, Galan P, Hercberg S, Jeandel C, Morris MC, Nourhashemi F, Payette H, Poulain JP, Portet F, Roussel AM, Ritz P, Rolland Y, Vellas B (2007) IANA task force on nutrition and cognitive decline with aging. J Nutr Health Aging 11, 132-152.
3. Seshadri S, Drachman DA, Lippa CF (1995) Apolipoprotein E epsilon 4 allele and the lifetime risk of Alzheimer's disease. What physicians know, and what they should know. Arch Neurol 52, 1074-1079.
4. Barberger-Gateau P, Raffaitin C, Letenneur L, Berr C, Tzourio C, Dartigues JF, Alperovitch A (2007) Dietary patterns and risk of dementia: The Three-City cohort study. Neurology 69, 1921-1930.
5. Luchsinger JA, Tang MX, Miller J, Green R, Mayeux R (2007) Relation of higher folate intake to lower risk of Alzheimer disease in the elderly. Arch Neurol 64, 86-92.
6. Kamphuis PJ, Scheltens P (2010) Can nutrients prevent or delay onset ofAlzheimer's disease? J Alzheimers Dis 20, 765-775.
7. Pocernich CB, Lange ML, Sultana R, Butterfield DA (2011) Nutritional approaches to modulate oxidative stress in Alzheimer's disease. Curr Alzheimer Res 8, 452-469.
8. Mi W, van Wijk N, Cansev M, Sijben JW, Kamphuis PJ (2013) Nutritional approaches in the risk reduction and management of Alzheimer's disease. Nutrition 29, 1080-1089.
9. Lopes da Silva S, Vellas B, Elemans S, Luchsinger J, Kamphuis P, Yaffe K, Sijben J, Groenendijk M, Stijnen T (2013) Plasma nutrient status of Alzheimer's disease patients compared to cognitive intact elderly controls: A systematic review and meta-analysis. Alzheimers Dement, doi: 10.1016/j.jalz.2013.1005.1771
10. Guigoz Y (2006) The Mini Nutritional Assessment (MNA) review of the literature-What does it tell us? J Nutr Health Aging 10, 466-485; discussion 485-467.
11. Buffa R, Mereu RM, Putzu PF, Floris G, Marini E (2010) Bioelectrical impedance vector analysis detects low body cell mass and dehydration in patients with Alzheimer's disease. J Nutr Health Aging 14, 823-827.
12. Gillioz AS, Villars H, Voisin T, Cortes F, Gillette-Guyonnet S, Andrieu S, Gardette V, Nourhashemi F, Ousset PJ, Jouanny P, Vellas B (2009) Spared and impaired abilities in community-dwelling patients entering the severe stage of Alzheimer's disease. Dement Geriatr Cogn Disord 28, 427-432.
13. Guerin O, Soto ME, Brocker P, Robert PH, Benoit M, Vellas B (2005) Nutritional status assessment during Alzheimer's disease: Results after one year (the REAL French Study Group). J Nutr Health Aging 9, 81-84.
14. Sandman PO, Adolfsson R, Nygren C, Hallmans G, Winblad B (1987) Nutritional status and dietary intake in institutionalized patients with Alzheimer's disease and multiinfarct dementia. J Am Geriatr Soc 35, 31-38.
15. Calvo I, Olivar J, Martinez E, Rico A, Diaz J, Gimena M (2012) MNA (R) Mini Nutritional Assessment as a nutritional screening tool for hospitalized older adults; rationales and feasibility. Nutr Hosp 27, 1619-1625.
16. Ousset PJ, Nourhashemi F, Reynish E, Vellas B (2008) Nutritional status is associated with disease progression in very mild Alzheimer disease. Alzheimer Dis Assoc Disord 22, 66-71.
17. Scheltens P, Twisk JW, Blesa R, Scarpini E, von Arnim CA, Bongers A, Harrison J, Swinkels SH, Stam CJ, de Waal H, Wurtman RJ, Wieggers RL, Vellas B, Kamphuis PJ (2012) Efficacy of Souvenaid in mild Alzheimer's disease: Results from a randomized, controlled trial. J Alzheimers Dis 31, 225-236.
18. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM (1984) Clinical diagnosis of Alzheimer's disease: Report ofthe NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 34, 939-944.
19. Vellas B, Villars H, Abellan G, Soto ME, Rolland Y, Guigoz Y, Morley JE, Chumlea W, Salva A, Rubenstein LZ, Garry P (2006) Overview of the MNA-Its history and challenges. J Nutr Health Aging 10, 456-463; discussion 463-455.
20. Rubenstein LZ, Harker JO, Salva A, Guigoz Y, Vellas B (2001) Screening for undernutrition in geriatric practice: Developing the short-form mini-nutritional assessment (MNA-SF). J Gerontol A Biol Sci Med Sci 56, M366-M372.
21. Guigoz Y (2006) The Mini Nutritional Assessment (MNA) review of the literature-What does it tell us? J Nutr Health Aging 10, 466-485; discussion 485-487.
22. Miller MD, Paradis CF, Houck PR, Mazumdar S, Stack JA, Rifai AH, Mulsant B, Reynolds CF, 3rd (1992) Rating chronic medical illness burdenin geropsychiatric practice and research: Application of the Cumulative Illness Rating Scale. Psychiatry Res 41, 237-248.
23. Fossati T, Colombo M, Castiglioni C, Abbiati G (1994) Determination of plasma choline by high-performance liquid chromatography with a postcolumn enzyme reactor and electrochemical detection. J Chromatogr B Biomed Appl 656, 59-64.
24. van Wijk N, Watkins CJ, Bohlke M, Maher TJ, Hageman RJ, Kamphuis PJ, Broersen LM, Wurtman RJ (2012) Plasma choline concentration varies with different dietary levels of vitamins B6, B12 and folic acid in rats maintained on choline-adequate diets. Br J Nutr 107, 1408-1412.
25. Catignani GL (1986) An HPLC method for the simultaneous determination of retinol and alpha-tocopherol in plasma or serum. Methods Enzymol 123, 215-219.
26. Kuo K, Still R, Cale S, McDowell I (1997) Standardization (external and internal) of HPLC assay for plasma homocys-teine. Clin Chem 43, 1653-1655.
27. Krijt J, Vackova M, Kozich V (2001) Measurement of homo-cysteine and other aminothiolsinplasma: Advantagesofusing tris (2-carboxyethyl) phosphine as reductant compared with tri-n-butylphosphine. Clin Chem 47, 1821-1828.
28. Wynants J, Van Belle H (1985) Single-run high-performance liquid chromatography of nucleotides, nucleosides, and major purine bases and its application to different tissue extracts. Anal Biochem 144, 258-266.
29. Folch J, Lees M, Sloane Stanley GH (1957) A simple method for the isolation and purification of total lipides from animal tissues. J Biol Chem 226, 497-509.
30. Kolarovic L, Fournier NC (1986) A comparison of extraction methods for the isolation of phospholipids from biological sources. Anal Biochem 156, 244-250.
31. Bligh EG, Dyer WJ (1959) A rapid method of total lipid extraction and purification. Can J Biochem Physiol 37, 911-917.
32. Morrison WR, Smith LM (1964) Preparation of fatty acid methyl esters and dimethylacetals from lipids with boron fluoride-methanol. J Lipid Res 5, 600-608.
33. Faxen-Irving G, Basun H, Cederholm T (2005) Nutritional and cognitive relationshipsand long-term mortalityinpatients with various dementia disorders. Age Ageing 34, 136-141.
34. Meulenbroek O, Rijpkema M, Kessels RP, Rikkert MG, Fernandez G (2010) Autobiographical memory retrieval in patients with Alzheimer's disease. Neuroimage 53, 331-340.
35. Aziz NA, van der Marck MA, Pijl H, Olde Rikkert MG, Bloem BR, Roos RA (2008) Weight lossin neurodegenerative disorders. J Neurol 255, 1872-1880.
36. Gillette-Guyonnet S, Nourhashemi F, Andrieu S, de Glisezin-ski I, Ousset PJ, Riviere D, Albarede JL, Vellas B (2000) Weight loss in Alzheimer disease. Am J Clin Nutr 71, 637S-642S.
37. Buchman AS, Wilson RS, Bienias JL, Shah RC, Evans DA, Bennett DA (2005) Change in body mass index and risk of incident Alzheimer disease. Neurology 65, 892-897.
38. Gu Y, Scarmeas N, Cosentino S, Brandt J, Albert M, Blacker D, Dubois B, Stern Y (2013) Change in body mass index before and after Alzheimer's disease onset. Curr Alzheimer Res, doi: CAR-EPUB-57541 [pii].
39. Droogsma E, van Asselt DZ, van Steijn JH, Schuur T, Huinink EJ (2013) Effect of long-term treatment with galantamine on weight of patients with Alzheimer's dementia. J Nutr Health Aging 17, 461-465.
40. Vural H, Demirin H, Kara Y, Eren I, Delibas N (2010) Alterations of plasma magnesium, copper, zinc, iron and selenium concentrations and some related erythrocyte antioxidant enzyme activitiesinpatients with Alzheimer's disease. J Trace Elem Med Biol 24, 169-173.
41. Cardoso BR, Ong TP, Jacob-Filho W, Jaluul O, Freitas MID, Cozzolino SMF (2010) Nutritional status of selenium in Alzheimer's disease patients. Br J Nutr 103, 803-806.
42. Basun H, Forssell LG, Wetterberg L, Winblad B (1991) Metals and trace elementsinplasma and cerebrospinalfluidinnormal aging and Alzheimer's disease. J Neural Transm Park Dis Dement Sect 3, 231-258.
43. Meseguer I, Molina JA, Jimenez-Jimenez FJ, Aguilar MV, Mateos-Vega CJ, Gonzalez-Munoz MJ, de Bustos F, Orti-Pareja M, Zurdo M, Berbel A, Barrios E, Martinez-Para MC (1999) Cerebrospinal fluid levels of selenium in patients with Alzheimer's disease. J Neural Transm 106, 309-315.
44. Loef M, Schrauzer GN, Walach H (2011) Selenium and Alzheimer's disease: A systematic review. J Alzheimers Dis 26, 81-104.
45. Shatenstein B, Kergoat MJ, Reid I (2007) Poor nutrient intakes during 1-year follow-up with community-dwelling older adults with early-stage Alzheimer dementia compared to cognitively intact matched controls. J Am Diet Assoc 107, 2091-2099.
46. Hibbeln JR, Nieminen LR, Blasbalg TL, Riggs JA, Lands WE (2006) Healthy intakes of n-3 and n-6 fatty acids: Estimations considering worldwide diversity. Am J Clin Nutr 83, 1483S-1493S.
47. Grimm MO, Rothhaar TL, Grosgen S, Burg VK, Hundsdorfer B, Haupenthal VJ, Friess P, Kins S, Grimm HS, Hartmann T (2012) Trans fatty acids enhance amyloidogenic processing of the Alzheimer amyloid precursor protein (APP). J Nutr Biochem23, 1214-1223.
48. Morris MC, Evans DA, Bienias JL, Tangney CC, Bennett DA, Aggarwal N, Schneider J, Wilson RS (2003) Dietary fats and the risk of incident Alzheimer disease. Arch Neurol 60, 194-200.
49. Engelhart MJ, Geerlings MI, Ruitenberg A, Van Swieten JC, Hofman A, Witteman JC, Breteler MM (2002) Diet and risk of dementia: Does fat matter? The Rotterdam Study. Neurology 59, 1915-1921.
50. Naqvi AZ, Harty B, Mukamal KJ, Stoddard AM, Vitolins M, Dunn JE (2011) Monounsaturated, trans, and saturated Fatty acids and cognitive decline in women. J Am Geriatr Soc 59, 837-843.
51. Katan MB, Deslypere JP, van Birgelen AP, Penders M, Zeg-waard M (1997) Kinetics of the incorporation of dietary fatty acids into serum cholesteryl esters, erythrocyte membranes, and adipose tissue: An 18-month controlled study. J Lipid Res 38, 2012-2022.
52. Selley ML (2007) A metabolic link between S-adenosylhomocysteine and polyunsaturated fatty acid metabolism in Alzheimer's disease. Neurobiol Aging 28, 1834-1839.
53. Astarita G, Jung KM, Berchtold NC, Nguyen VQ, Gillen DL, Head E, Cotman CW, Piomelli D (2010) Deficient liver biosynthesis of docosahexaenoic acid correlates with cognitive impairment in Alzheimer's disease. PLoS One 5, e12538.
54. Lin PY, Chiu CC, Huang SY, Su KP (2012) A meta-analytic review of polyunsaturated fatty acid compositions in dementia. J Clin Psychiatry 73, 1245-1254.
55. Trushina E, Dutta T, Persson XM, Mielke MM, Petersen RC (2013) Identification of altered metabolic pathways in plasma and CSF in mild cognitive impairment and Alzheimer's dis ease using metabolomics. PLoS One 8, e63644.
56. Cansev M (2006) Uridine and cytidine in the brain: Their transport and utilization. Brain Res Rev 52, 389-397.
57. Nitsch RM, Blusztajn JK, Pittas AG, Slack BE, Growdon JH, Wurtman RJ (1992) Evidence for a membrane defect in Alzheimer disease brain. Proc Natl Acad Sci USA 89, 1671-1675.
58. Pettegrew JW, Panchalingam K, Hamilton RL, McClure RJ (2001) Brain membrane phospholipid alterations in Alzheimer's disease. Neurochem Res 26, 771-782.
59. Sakamoto T, Cansev M, Wurtman RJ (2007) Oral supplementation with docosahexaenoic acid and uridine-5'-monophosphate increases dendritic spine density in adult gerbil hippocampus. Brain Res 1182, 50-59.
60. Czech C, Berndt P, Busch K, Schmitz O, Wiemer J, Most V, Hampel H, Kastler J, Senn H (2012) Metabolite profiling of Alzheimer's disease cerebrospinal fluid. PLoS One 7, e31501.
61. Soderberg M, Edlund C, Kristensson K, Dallner G (1991) Fatty acid composition of brain phospholipids in aging and in Alzheimer's disease. Lipids 26, 421-425.
62. Prasad MR, Lovell MA, Yatin M, Dhillon H, Markesbery WR (1998) Regional membrane phospholipid alterations in Alzheimer's disease. Neurochem Res 23, 81-88.
63. Eastley R, Wilcock GK, Bucks RS (2000) Vitamin B12 deficiency in dementia and cognitive impairment: The effects of treatment on neuropsychological function. Int J Geriatr Psychiatry 15, 226-233.
64. Farina N, Isaac MG, Clark AR, Rusted J, Tabet N (2012) Vitamin E for Alzheimer's dementia and mild cognitive impairment. Cochrane Database Syst Rev 11, CD002854.
65. Quinn JF, Raman R, Thomas RG, Yurko-Mauro K, Nelson EB, Van Dyck C, Galvin JE, Emond J, Jack CR Jr, Weiner M, Shinto L, Aisen PS (2010) Docosahexaenoic acid supplementation and cognitive decline in Alzheimer disease: A randomized trial. JAMA 304, 1903-1911.
66. Jacobs DR Jr, Gross MD, Tapsell LC (2009) Food synergy: An operational concept for understanding nutrition. Am J Clin Nutr 89, 1543S-1548S.
67. Scheltens P, Kamphuis PJ, Verhey FR, Olde Rikkert MG, Wurtman RJ, Wilkinson D, Twisk JW, Kurz A (2010) Efficacy of a medical foodin mild Alzheimer's disease: A randomized, controlled trial. Alzheimers Dement 6, 1-10 e11.
68. Estruch R, Ros E, Salas-Salvado J, Covas MI, Corella D, Aros F, Gomez-Gracia E, Ruiz-Gutierrez V, Fiol M, Lapetra J, Lamuela-Raventos RM, Serra-Majem L, Pinto X, Basora J, Munoz MA, Sorli JV, Martinez JA, Martinez-Gonzalez MA (2013) Primary prevention of cardiovascular disease with a Mediterranean diet. N Engl J Med 368, 1279-1290.